Latest Dual Listing News

Predictive Discovery Limited has finalized its acquisition of Robex Resources, creating a combined entity aiming for over 400,000 ounces of gold production annually by 2029. The merger consolidates two key West African gold projects under one ASX and TSX-listed company.

ADX Energy has kicked off drilling mobilisation for its HOCH-1 shallow gas well in Upper Austria, aiming to tap prospective resources up to 17.3 billion cubic feet. The well spud is slated for mid-April, marking the first of three permitted gas prospects in 2026.

Auckland International Airport confirms the share allotment price for its Dividend Reinvestment Plan tied to the 2025 half-year dividend, signalling steady shareholder returns.

Winsome Resources Limited is set to be acquired by Li-FT Power Ltd through a scheme of arrangement, consolidating key lithium assets and creating a dual-listed entity on ASX and TSXV.

ADX Energy has secured A$4.4 million through a well-supported placement to fund key exploration projects in Austria and Italy, alongside plans for a strategic dual listing on Oslo Børs’ Euronext Growth market.

ADX Energy has secured a crucial extension on its loan note repayments, unlocking financial flexibility to advance multiple drilling and development projects across Austria and Italy.

Anteris Technologies Global Corp. posted a $94.2 million loss for 2025 amid a 29% revenue decline, while progressing its pivotal DurAVR THV clinical trial and securing $320 million in early 2026 financings.

Bioxyne Limited has reported a remarkable half-year performance, with revenues soaring 149% to $31.3 million and net profit more than doubling to $7.3 million, driven by strong demand for medicinal cannabis, MDMA, and psilocybin products and expanding international operations.

Amaero Ltd has announced plans to re-domicile from Australia to the United States, aiming to tap into larger capital markets and position itself for a potential US IPO by late 2026 or early 2027. The move retains its ASX listing while opening doors to broader investor pools and strategic growth opportunities.

News Corp will temporarily halt conversions between its Australian and US securities registers around the March 2026 dividend record date to ensure equal treatment of shareholders.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

Zip Co has delivered a standout half-year performance with record cash earnings and upgraded FY26 guidance, driven by strong US market momentum and innovative product launches.